Lexapro is the Leading Single Agent In First- and Second-Line Patient Share for the Treatment of Generalized Anxiety Disorder
WALTHAM, Mass., June 18 /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Lexapro is the leading single agent used in anxiety therapy with 11.7 percent and 14.9 percent of first- and second-line patient share, respectively. According to surveyed psychiatrists and primary […]